Area of research
Psychiatry and Mental health · Cognitive Neuroscience
Research interest
Research focused on Neuroimaging and Alzheimer's Disease Neuroimaging Initiative, with related work in Cognitive impairment, Genome-wide association study, Hippocampal formation. Notable publications include 'Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults', 'Visual contrast sensitivity in Alzheimer’s disease, mild cognitive impairment, and older adults with cognitive complaints', and 'GWAS of longitudinal amyloid accumulation on 18 F-florbetapir PET in Alzheimer’s disease implicates microglial activation gene IL1RAP'.
Associations of the Top 20 Alzheimer Disease Risk Variants With Brain Amyloidosis
IC‐P‐178: COMPARING HIPPOCAMPAL EFFECT SIZE BETWEEN ALZHEIMER'S DISEASE AND HEALTHY CONTROLS USING OLDER AND NEWER VERSIONS OF SPM AND FREESURFER
P3‐377: COMPARING HIPPOCAMPAL EFFECT SIZE BETWEEN ALZHEIMER'S DISEASE AND HEALTHY CONTROLS USING OLDER AND NEWER VERSIONS OF SPM AND FREESURFER
Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer’s Disease
Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults
GWAS of longitudinal amyloid accumulation on<sup>18</sup>F-florbetapir PET in Alzheimer’s disease implicates microglial activation gene<i>IL1RAP</i>
Visual contrast sensitivity in Alzheimer’s disease, mild cognitive impairment, and older adults with cognitive complaints
Voxel and surface-based topography of memory and executive deficits in mild cognitive impairment and Alzheimer’s disease